Quotient Limited - Ordinary Shares (QTNT): Price and Financial Metrics


Quotient Limited - Ordinary Shares (QTNT): $4.23

-0.12 (-2.76%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

QTNT POWR Grades


  • QTNT scores best on the Growth dimension, with a Growth rank ahead of 49.99% of US stocks.
  • QTNT's strongest trending metric is Growth; it's been moving down over the last 31 weeks.
  • QTNT's current lowest rank is in the Value metric (where it is better than 31.4% of US stocks).

QTNT Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for QTNT is -1.49 -- better than just 3.64% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -52.53 for Quotient Ltd; that's greater than it is for merely 0.39% of US stocks.
  • Quotient Ltd's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -18.55%, greater than the shareholder yield of merely 13.2% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Quotient Ltd are CCLP, LTRPA, CIDM, GDDY, and HRB.
  • Visit QTNT's SEC page to see the company's official filings. To visit the company's web site, go to quotientbd.com.

QTNT Price Target

For more insight on analysts targets of QTNT, see our QTNT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.50 Average Broker Recommendation 1.38 (Strong Buy)

QTNT Stock Price Chart Interactive Chart >

Price chart for QTNT

QTNT Price/Volume Stats

Current price $4.23 52-week high $8.77
Prev. close $4.35 52-week low $3.41
Day low $4.23 Volume 215,510
Day high $4.36 Avg. volume 693,788
50-day MA $4.01 Dividend yield N/A
200-day MA $4.98 Market Cap 429.46M

Quotient Limited - Ordinary Shares (QTNT) Company Bio


Quotient Limited develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company was founded in 2007 and is based in Penicuik, the United Kingdom.


QTNT Latest News Stream


Event/Time News Detail
Loading, please wait...

QTNT Latest Social Stream


Loading social stream, please wait...

View Full QTNT Social Stream

Latest QTNT News From Around the Web

Below are the latest news stories about Quotient Ltd that investors may wish to consider to help them evaluate QTNT as an investment opportunity.

10 Best Stocks to Buy According to Highbridge Capital

In this article we will take a look at the 10 best stocks to buy according to billionaire Glenn Russell Dubin’s Highbridge Capital Management. You can skip our detailed analysis of Dubin’s history, investment philosophy, and hedge fund performance, and go directly to the 5 Best Stocks to Buy According to Billionaire Glenn Russell Dubin’s […]

Yahoo | June 10, 2021

BTIG Keeps Their Buy Rating on Quotient (QTNT)

BTIG analyst Sung Ji Nam maintained a Buy rating on Quotient (QTNT) on June 2 and set a price target of $13.00. The post BTIG Keeps Their Buy Rating on Quotient (QTNT) appeared first on Smarter Analyst .

Smarter Analyst | June 9, 2021

Quotient''s Debt Insights

Shares of Quotient (NASDAQ: QTNT ) fell by nan% in the past three months. Before having a look at the importance of debt, let us look at how much debt Quotient has. Quotient''s Debt According to the Quotient''s most recent financial statement as reported on February 4, 2021, total debt is at $161.12 million, with $136.07 million in long-term debt and $25.05 million in current debt. Adjusting for $3.40 million in cash-equivalents, the company has a net debt of $157.72 million. Let''s define some of the terms we used in the paragraph above. Current debt is the portion of a company''s debt which is due within 1 year, while long-term Full story available on Benzinga.com

Benzinga | June 2, 2021

Quotient's Debt Insights

Shares of Quotient (NASDAQ: QTNT ) fell by nan% in the past three months. Before having a look at the importance of debt, let us look at how much debt Quotient has. Quotient's Debt According to the Quotient's most recent financial statement as reported on February 4, 2021, total debt is at $161.12 million, with $136.07 million in long-term debt and $25.05 million in current debt. Adjusting for $3.40 million in cash-equivalents, the company has a net debt of $157.72 million. Let's define some of the terms we used in the paragraph above. Current debt is the portion of a company's debt which is due within 1 year, while long-term … Full story available on Benzinga.com

Benzinga | June 2, 2021

Quotient Limited (QTNT) CEO Manuel Mendez on Q4 2021 Results - Earnings Call Transcript

Quotient Limited (QTNT) Q4 2021 Earnings Conference Call June 1, 2021 08:00 ET Company Participants Peter Buhler - Chief Financial Officer Manuel Mendez - Chief Executive Officer Conference Call Participants Sung Ji Nam - BTIG Josh Jennings - Cowen and Company Brandon Couillard - Jefferies Presentation Operator Greetings. Welcome to...

SA Transcripts on Seeking Alpha | June 1, 2021

Read More 'QTNT' Stories Here

QTNT Price Returns

1-mo 2.92%
3-mo 2.42%
6-mo -42.21%
1-year -47.06%
3-year -48.35%
5-year -52.79%
YTD -18.81%
2020 -45.22%
2019 55.39%
2018 23.64%
2017 2.27%
2016 -69.75%

Continue Researching QTNT

Want to see what other sources are saying about Quotient Ltd's financials and stock price? Try the links below:

Quotient Ltd (QTNT) Stock Price | Nasdaq
Quotient Ltd (QTNT) Stock Quote, History and News - Yahoo Finance
Quotient Ltd (QTNT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.9651 seconds.